Population Pharmacokinetic Model with Sparse Sampling for Mycophenolic Acid in Liver Transplant Patients

被引：0
|
作者：
Wang, Xiaoxing [1 ]
Chen, Bing [2 ]
Smith, David [1 ]
Feng, Meihua Rose [1 ]
机构：
[1] Univ Michigan, Coll Pharm, 428 Church St, Ann Arbor, MI 48109 USA
[2] Shanghai Jiaotong Univ Sch Med, Shanghai, Peoples R China
来源：
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS | 2014年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
M-056
引用
收藏
页码：S31 / S31
页数：1
相关论文
共 50 条
  • [21] Correlation Between Pharmacokinetics and Pharmacodynamics of Mycophenolic Acid in Liver Transplant Patients
    Shi Minmin
    Gu Zhidong
    Chen Hao
    Zhang Weixia
    Shen Baiyong
    Chen Bing
    Shen Chuan
    Deng Xiaxing
    Zhan Xi
    JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (12): : 1388 - 1396
  • [22] Intraindividual and interindividual variations in the pharmacokinetics of mycophenolic acid in liver transplant patients
    Pisupati, J
    Jain, A
    Burckart, G
    Hamad, I
    Zuckerman, S
    Fung, J
    Venkataramanan, R
    JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 45 (01): : 34 - 41
  • [23] Population pharmacokinetics of mycophenolic acid in kidney transplant pediatric and adolescent patients
    Payen, S
    Zhang, D
    Maisin, A
    Popon, M
    Bensman, A
    Bouissou, F
    Loirat, C
    Gomeni, R
    Bressolle, E
    Jacqz-Aigrain, E
    THERAPEUTIC DRUG MONITORING, 2005, 27 (03) : 378 - 388
  • [24] Effect of Time after Transplantation on Mycophenolic Acid Pharmacokinetic in Kidney Transplant Patients in Iran
    Mohammadpour, A. H.
    Vahabzadeh, M.
    Abedi, H.
    TRANSPLANTATION, 2012, 94 (10) : 837 - 837
  • [25] Limited Sampling Strategy of Mycophenolic Acid in Adult Kidney Transplant Recipients: Influence of the Post-Transplant Period and the Pharmacokinetic Profile
    Chaabane, Amel
    Aouam, Karim
    Ben Fredj, Nadia
    Hammouda, Mouna
    Chadly, Zohra
    El May, Mezri
    Boughattas, Naceur
    Skhiri, Habib
    JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 53 (09): : 925 - 933
  • [26] Population pharmacokinetic (PK) model of mycophenolic acid (MPA) and its metabolite - Mycophenolic acid glucoronide (MPAG) in long term transplant renal patients using Montecarlo parametric expectation maximization (MC-PEM).
    Okusanya, O. O.
    Dole, K.
    Zack, J.
    Forrest, A.
    Gundroo, A.
    Leca, N.
    Venuto, R. C.
    Tornatore, K. M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 : S72 - S72
  • [27] Pharmacokinetic monitoring of mycophenolic acid in heart transplant patients: Correlation the side-effects and rejections with pharmacokinetic parameters
    Figurski, Michal J.
    Pawinski, Tomasz
    Goldberg, Lee R.
    DeNofrio, David
    Nawrocki, Artur
    Taylor, David O.
    Lake, Kathleen D.
    Chojnowski, Donna
    Shaw, Leslie M.
    ANNALS OF TRANSPLANTATION, 2012, 17 (01) : 68 - 78
  • [28] DEVELOPMENT OF A POPULATION PHARMACOKINETIC MODEL WITH ENTEROHEPATIC RECIRCULATION FOR MYCOPHENOLIC ACID IN PATIENTS WITH CHILDHOOD SYSTEMIC LUPUS ERYTHEMATOSUS (cSLE).
    Sherwin, C. M.
    Sagcal-Gironella, A.
    Fukuda, T.
    Brunner, H. I.
    Vinks, A. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 : S61 - S61
  • [29] Explaining variability in mycophenolic acid exposure to optimize mycophenolate mofetil dosing: A population pharmacokinetic meta-analysis of mycophenolic acid in renal transplant recipients
    van Hest, Reinier M.
    Mathot, Ron A. A.
    Pescovitz, Mark D.
    Gordon, Robert
    Mamelok, Richard D.
    van Gelder, Teun
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (03): : 871 - 880
  • [30] Therapeutic drug monitoring of mycophenolic acid in kidney transplant patients: A abbreviated sampling strategy
    Muller, H.
    Solari, S.
    Zuniga, C.
    Guerra, I.
    Troncoso, J.
    Ovalle, R.
    Morente, J.
    Pedreros, C.
    TRANSPLANTATION PROCEEDINGS, 2007, 39 (03) : 596 - 599
12345